Postpartum Hemorrhage
📧 Sign up to get email alerts when something new happens for Postpartum Hemorrhage.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-26Clinical Trial Update: Does Cold Saline Used to Inflate a Balloon Tamponade Catheter More Significantly Reduce Blood Loss From Postpartum Hemorrhage Than Room Temperature Saline? [NA]
A clinical trial evaluating whether cold saline inflated in a balloon tamponade catheter reduces blood loss in postpartum hemorrhage more ef…
-
CLINICAL_TRIALS withdrawal · 2024-12-10Clinical Trial Update: High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth [Phase 2]
A Phase 2 trial evaluating high versus low dose oxytocin given at cesarean birth to address postpartum hemorrhage has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-02-08Clinical Trial Update: Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015) [Phase 3]
Clinical trial comparing tranexamic acid to oxytocin for postpartum hemorrhage was withdrawn (Phase 3).
-
CLINICAL_TRIALS withdrawal · 2024-01-26Clinical Trial Update: Prevention of Postpartum Hemorrhage With TXA [Phase 4]
A Phase 4 trial evaluating tranexamic acid (TXA) for prevention of postpartum hemorrhage has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-21Clinical Trial Update: Oxytocin Dosing at Planned Cesarean Section and Anemia [Phase 4]
A Phase 4 trial evaluating oxytocin dosing during planned cesarean section was withdrawn, with relevance to anemia from blood loss and uteri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-07-31Clinical Trial Update: An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery [Phase 4]
A Phase 4 trial evaluating an evidence-based protocol for oxytocin administration in vaginal delivery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities [Phase 3]
Phase 3 trial evaluating misoprostol and oxytocin delivered in Uniject for postpartum hemorrhage prevention in communities has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2014-01-09Clinical Trial Update: Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali [NA]
A clinical trial comparing misoprostol and oxytocin in Uniject for postpartum hemorrhage prevention in Mali has been withdrawn from enrollme…
-
CLINICAL_TRIALS withdrawal · 2013-08-23Clinical Trial Update: HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency
HEMOLEVEN Expanded Access Program for prevention of surgical and postpartum hemorrhage in people with severe inherited Factor XI deficiency …
-
CLINICAL_TRIALS withdrawal · 2012-01-11Clinical Trial Update: Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? [Phase 4]
A Phase 4 trial evaluating intramyometrial oxytocin during elective cesarean delivery has been withdrawn. The study was associated with post…
-
CLINICAL_TRIALS withdrawal · 2012-01-09Clinical Trial Update: Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India [NA]
The clinical trial evaluating the effectiveness, safety, and feasibility of administering oxytocin via Uniject by auxiliary nurse midwives t…